RBC Capital Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $165
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh initiates coverage on DexCom (NASDAQ:DXCM) with an Outperform rating and a price target of $165.
March 12, 2024 | 11:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has initiated coverage on DexCom with an Outperform rating and set a price target of $165.
The initiation of coverage by RBC Capital with an Outperform rating and a high price target of $165 is likely to generate positive sentiment among investors, potentially driving up the stock price in the short term. Analyst ratings, especially from reputable firms, can significantly influence investor perception and stock price movements.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100